Pyrazolo[3,4-d]pyrimidines as Potent Antiproliferative and Proapoptotic Agents toward A431 and 8701-BC Cells in Culture via Inhibition of c-Src Phosphorylation

We report here the synthesis of new pyrazolo[3,4-d]pyrimidine derivatives along with their biological properties as inhibitors of isolated Src and cell line proliferation (A431 and 8701-BC cells). Such compounds block the growth of cancer cells by interfering with the phosphorylation of Src, and the...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 49; no. 5; pp. 1549 - 1561
Main Authors Carraro, Fabio, Naldini, Antonella, Pucci, Annalisa, Locatelli, Giada A, Maga, Giovanni, Schenone, Silvia, Bruno, Olga, Ranise, Angelo, Bondavalli, Francesco, Brullo, Chiara, Fossa, Paola, Menozzi, Giulia, Mosti, Luisa, Modugno, Michele, Tintori, Cristina, Manetti, Fabrizio, Botta, Maurizio
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 09.03.2006
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:We report here the synthesis of new pyrazolo[3,4-d]pyrimidine derivatives along with their biological properties as inhibitors of isolated Src and cell line proliferation (A431 and 8701-BC cells). Such compounds block the growth of cancer cells by interfering with the phosphorylation of Src, and they act as proapoptotic agents through the inhibition of the anti apoptotic gene BCL2. Several of them were found to be more active than the reference compound (1-(tert-butyl)-3-(4-chlorophenyl)-4-aminopyrazolo[3,4-d]pyrimidine, PP2) in inhibiting cell proliferation and in inducing apoptosis, and as active as PP2 in the inhibition of the phosphorylation of isolated Src. Moreover, molecular modeling simulations have been performed to hypothesize the way, at the molecular level, by which the inhibitors were able to act as antiproliferative agents.
Bibliography:ark:/67375/TPS-9JS0HM25-W
istex:9F339E44CDB999AE3306A5AE51C4F8C4943510E7
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-2623
1520-4804
DOI:10.1021/jm050603r